SciCombinator

Discover the most talked about and latest scientific content & concepts.

A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19

OPEN The New England journal of medicine | 4 Jun 2020

DR Boulware, MF Pullen, AS Bangdiwala, KA Pastick, SM Lofgren, EC Okafor, CP Skipper, AA Nascene, MR Nicol, M Abassi, NW Engen, MP Cheng, D LaBar, SA Lother, LJ MacKenzie, G Drobot, N Marten, R Zarychanski, LE Kelly, IS Schwartz, EG McDonald, R Rajasingham, TC Lee and KH Hullsiek
Abstract
Coronavirus disease 2019 (Covid-19) occurs after exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). For persons who are exposed, the standard of care is observation and quarantine. Whether hydroxychloroquine can prevent symptomatic infection after SARS-CoV-2 exposure is unknown.
Tweets*
9383
Facebook likes*
32
Reddit*
9
News coverage*
417
Blogs*
35
SC clicks
2
Concepts
-
MeSH headings
-
comments powered by Disqus

* Data courtesy of Altmetric.com